Literature DB >> 30283713

Allergic Diseases and Immune-Mediated Food Disorders in Pediatric Acute-Onset Neuropsychiatric Syndrome.

Jaime S Rosa1,2, Joseph D Hernandez1,2, Janell A Sherr1,2, Bridget M Smith3,4, Kayla D Brown2, Bahare Farhadian2, Talia Mahony2, Sean A McGhee1, David B Lewis1,2, Margo Thienemann2, Jennifer D Frankovich1,2.   

Abstract

Background: The prevalence and impact of allergic and immune-mediated food disorders in pediatric acute-onset neuropsychiatric syndrome (PANS) are mostly unknown. Objective: We sought to explore the prevalence of atopic dermatitis (AD), asthma, allergic rhinitis (AR), IgE-mediated food allergies (FAs), and other immune-mediated food disorders requiring food avoidance in patients with PANS. In addition, to further understand the extent of food restriction in this population, we investigated the empiric use of dietary measures to improve PANS symptoms.
Methods: Pediatric patients in a PANS Clinic and Research Program were given surveys regarding their caregiver burdens, allergic and food-related medical history, and whether food elimination resulted in perception of improvement of PANS symptoms. A review of health records was conducted to confirm that all responses in the survey were concordant with documentation of each patient's medical chart.
Results: Sixty-nine (ages 4-20 years) of 80 subjects who fulfilled PANS criteria completed the surveys. Thirteen (18.8%) had AD, 11 (15.9%) asthma, 33 (47.8%) AR, 11 (15.9%) FA, 1 (1.4%) eosinophilic gastrointestinal disorders, 1 (1.4%) food protein-induced enterocolitis syndrome, 3 (4.3%) milk protein-induced proctocolitis syndrome, and 3 (4.3%) celiac disease. Thirty subjects (43.5%) avoided foods due to PANS; elimination of gluten and dairy was most common and was associated with perceived improvement of PANS symptoms (by parents). This perceived improvement was not confirmed with objective data. Conclusions: The prevalence of allergic and immune-mediated food disorders in PANS is similar to the general population as reported in the literature, with the exception of AR that appears to be more prevalent in our PANS cohort. More research will be required to establish whether diet or allergies influence PANS symptoms.

Entities:  

Keywords:  allergies; celiac; elimination; food; immunologic; pediatric neuropsychiatric disorder

Year:  2018        PMID: 30283713      PMCID: PMC6154445          DOI: 10.1089/ped.2018.0888

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol Pulmonol        ISSN: 2151-321X            Impact factor:   1.349


  26 in total

1.  Pediatric Acute-Onset Neuropsychiatric Syndrome Response to Oral Corticosteroid Bursts: An Observational Study of Patients in an Academic Community-Based PANS Clinic.

Authors:  Kayla Brown; Cristan Farmer; Bahare Farhadian; Joseph Hernandez; Margo Thienemann; Jennifer Frankovich
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-17       Impact factor: 2.576

2.  A pilot trial of cognitive-behavioral therapy augmentation of antibiotic treatment in youth with pediatric acute-onset neuropsychiatric syndrome-related obsessive-compulsive disorder.

Authors:  Joshua M Nadeau; Cary Jordan; Robert R Selles; Monica S Wu; Morgan A King; Priyal D Patel; Camille E Hanks; Elysse B Arnold; Adam B Lewin; Tanya K Murphy; Eric A Storch
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-05       Impact factor: 2.576

3.  Application of a multidimensional caregiver burden inventory.

Authors:  M Novak; C Guest
Journal:  Gerontologist       Date:  1989-12

4.  Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder.

Authors:  Emily G Severance; Kristin L Gressitt; Shuojia Yang; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Faith B Dickerson; Robert H Yolken
Journal:  Bipolar Disord       Date:  2013-12-06       Impact factor: 6.744

5.  Five youth with pediatric acute-onset neuropsychiatric syndrome of differing etiologies.

Authors:  Jennifer Frankovich; Margo Thienemann; Sonal Rana; Kiki Chang
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-02       Impact factor: 2.576

6.  Use of intravenous immunoglobulin in the treatment of twelve youths with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

Authors:  Miro Kovacevic; Paul Grant; Susan E Swedo
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-02-06       Impact factor: 2.576

7.  Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference.

Authors:  Kiki Chang; Jennifer Frankovich; Michael Cooperstock; Madeleine W Cunningham; M Elizabeth Latimer; Tanya K Murphy; Mark Pasternack; Margo Thienemann; Kyle Williams; Jolan Walter; Susan E Swedo
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-10-17       Impact factor: 2.576

8.  Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.

Authors:  S J Perlmutter; S F Leitman; M A Garvey; S Hamburger; E Feldman; H L Leonard; S E Swedo
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

Review 9.  The relationship of autism and gluten.

Authors:  Timothy Buie
Journal:  Clin Ther       Date:  2013-05       Impact factor: 3.393

Review 10.  Systematic review of nutrient intake and growth in children with multiple IgE-mediated food allergies.

Authors:  Cassandra Sova; Mary Beth Feuling; Megan Baumler; Linda Gleason; Jonathan S Tam; Heidi Zafra; Praveen S Goday
Journal:  Nutr Clin Pract       Date:  2013-10-28       Impact factor: 3.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.